ESC 365 - State-of-the-art in risk stratification in heart disease: the power of molecular tools

ESC Premium Access

State-of-the-art in risk stratification in heart disease: the power of molecular tools

Session: Risk stratification in heart disease: the power of molecular tools

Topic: Epidemiology, Prognosis, Outcome

Speaker: Associate Professor J. Leopold (Boston, US)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Associate Professor Jane A Leopold

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

1 presentation

0 follower

2 more presentations in this session

Common genetic variants improve risk stratification after atrial switch operation for transposition of the great arteries

Speaker: Ms O. Woudstra (Amsterdam, NL)

Proteomics profiling reveals distinct molecular subtypes of hypertrophic cardiomyopathy with differential risks of major adverse cardiovascular events

Speaker: Doctor L. Liang (New York, US)

Access the full session

Risk stratification in heart disease: the power of molecular tools

Speakers: Associate Professor J. Leopold, Ms O. Woudstra, Doctor L. Liang

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources